Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 2.12 Billion

CAGR (2026-2031)

10.79%

Fastest Growing Segment

Home Care Settings

Largest Market

North America

Market Size (2031)

USD 3.92 Billion

Market Overview

The Global Veterinary Point of Care Diagnostics Market is projected to grow from USD 2.12 Billion in 2025 to USD 3.92 Billion by 2031 at a 10.79% CAGR. Veterinary Point of Care diagnostics comprise portable testing instruments and consumables that enable veterinarians to perform immediate analyses at the site of animal care rather than utilizing external reference laboratories. The primary driver supporting this market is the rising prevalence of companion animal ownership combined with the increasing willingness of owners to invest in premium healthcare services. This surge in demand necessitates rapid clinical decision-making capabilities that allow practitioners to diagnose and initiate treatment during a single consultation. According to FEDIAF, in 2025, 139 million European households owned at least one pet. This substantial ownership base underscores the expanding addressable market for immediate diagnostic solutions globally.

Despite these strong growth indicators the market faces a significant impediment regarding the shortage of skilled veterinary professionals which limits the capacity of clinics to adopt and manage new diagnostic workflows. The scarcity of trained staff can lead to the underutilization of available technologies and hinders the overall expansion of point of care testing within veterinary practices efficiently.

Key Market Drivers

Technological advancements in portable and automated diagnostic systems are fundamentally reshaping the Global Veterinary Point of Care Diagnostics Market by enabling reference-lab quality results within the clinic. The integration of artificial intelligence and connectivity into benchtop analyzers allows veterinarians to obtain immediate, accurate interpretations of complex samples, thereby facilitating real-time treatment decisions. This shift is rapidly accelerating the installation of sophisticated hardware in practices worldwide. For instance, according to IDEXX Laboratories, Inc., November 2025, in the 'Third Quarter Results', the company placed over 1,700 units of its innovative inVue Dx instruments globally during just that quarter, reflecting the intense operational demand for these advanced diagnostic capabilities.

Increasing animal healthcare expenditure and pet insurance penetration further catalyze market expansion by removing financial barriers to comprehensive testing. As insurance coverage becomes more widespread, pet owners are increasingly able to authorize extensive diagnostic panels during initial visits without cost concerns, ensuring higher utilization rates of point of care devices. According to the North American Pet Health Insurance Association (NAPHIA), April 2025, in the 'State of the Industry Report 2025', the sector's total written premium exceeded $5.2 billion USD at the end of 2024, demonstrating the substantial monetary growth supporting veterinary services. This financial backing is mirrored by broader spending habits; according to the American Pet Products Association, in 2025, total pet industry expenditures in the United States reached $152 billion for the preceding year, underscoring the robust economic environment fueling diagnostic adoption.

Download Free Sample Report

Key Market Challenges

The shortage of skilled veterinary professionals acts as a critical bottleneck hampering the growth of the Global Veterinary Point of Care Diagnostics Market. While point of care devices are designed to accelerate clinical decision-making, they require a baseline of available personnel to operate the instruments, interpret results, and maintain the equipment. When clinics suffer from staffing deficits, the existing veterinary teams are often overwhelmed with patient volume, leaving them with insufficient bandwidth to integrate new diagnostic workflows or undergo the necessary training for advanced portable systems. Consequently, practices frequently revert to sending samples to external reference laboratories to conserve immediate staff resources, effectively neutralizing the speed advantage that drives the adoption of point of care solutions.

This labor constraint is severely impacting market expansion by creating an environment of instability where practice owners are hesitant to invest in premium technology. According to the British Veterinary Association, in 2024, more than one-third of veterinarians reported that they were unsure of their future in the sector or were actively planning to leave the profession entirely. This high rate of potential turnover exacerbates the workforce crisis, directly limiting the capacity of veterinary clinics to utilize and justify the cost of immediate diagnostic instruments.

Key Market Trends

Advancements in Microfluidic and Lab-on-a-Chip Technologies are fundamentally altering the physical footprint and operational efficiency of veterinary clinics by miniaturizing complex fluid handling into single-use cartridges. This architectural shift allows practitioners to analyze significantly smaller sample volumes, which is critical for pediatric or dehydrated animal patients, while simultaneously eliminating the extensive maintenance and liquid reagent storage required by traditional benchtop systems. By manipulating fluids at the sub-millimeter scale, these compact devices enable precise cellular alignment and immediate analysis without the need for large-scale laboratory infrastructure. According to Zoetis Inc., September 2024, in the 'Zoetis to Introduce First Cartridge-Based AI-Powered Hematology Analyzer' press release, the company unveiled the Vetscan OptiCell, a diagnostic instrument utilizing proprietary microfluidic technology to align blood cells in a single layer for analysis, marking a significant departure from standard flow cytometry methods.

Concurrently, the market is undergoing a decisive Shift Towards Cloud-Based Practice Management Integration, transforming diagnostic instruments from standalone tools into connected nodes within a digital ecosystem. This trend focuses on the workflow efficiency derived from synchronizing point-of-care hardware directly with patient information systems, ensuring that test results are automatically populated into medical records to prevent manual entry errors and guarantee accurate billing capture. Veterinary practices are prioritizing these integrated platforms to facilitate longitudinal patient tracking and streamline the administrative burden associated with high-volume testing. According to IDEXX Laboratories, Inc., October 2024, in the 'Q3 2024 Earnings Highlights', the company reported that revenue from its Veterinary Software, Services and Diagnostic Imaging segment increased 11% on a reported basis, a performance specifically driven by the continued double-digit organic growth of its cloud-based software solutions.

Segmental Insights

The Home Care Settings segment is currently identified as the fastest-growing area within the Global Veterinary Point of Care Diagnostics Market. This distinct upward trend is driven by an increasing demand from pet owners for immediate and convenient health monitoring solutions. The rising incidence of chronic diseases, such as diabetes, necessitates frequent testing that is both cost-effective and manageable outside traditional clinical environments. Additionally, the availability of user-friendly portable diagnostic devices facilitates this shift, allowing owners to conduct routine assessments efficiently, thereby reducing the stress and expense associated with repeated veterinary clinic visits.

Regional Insights

North America maintains a leading position in the veterinary point of care diagnostics market, driven by widespread pet ownership and substantial animal healthcare expenditure. The region benefits from an established infrastructure of veterinary clinics and hospitals that prioritize rapid testing solutions for efficient disease management. Additionally, the presence of major market participants in the United States facilitates accessible distribution channels. The strong regulatory framework, supported by the United States Department of Agriculture for diagnostic kit approval, ensures product reliability and further stabilizes market growth within the region.

Recent Developments

  • In December 2024, Zoetis Inc. announced the global launch of the Vetscan OptiCell, a new screenless point-of-care hematology analyzer, ahead of its showcase at the Veterinary Meeting & Expo in January 2025. This cartridge-based diagnostic tool integrates artificial intelligence with proprietary viscoelastic focusing technology to provide complete blood count (CBC) analysis with reference laboratory quality accuracy. The system was designed to align cells in a single layer for sharp imaging, minimizing errors and enabling precise platelet recognition. The launch aimed to offer veterinary clinics a compact, maintenance-free solution that delivers rapid insights and improves operational efficiency.
  • In July 2024, Bionote USA announced a strategic partnership with MWI Animal Health to expand the distribution of its veterinary diagnostic products across the United States. This collaboration enabled MWI Animal Health to distribute Bionote’s Vcheck line of quantitative in-clinic analyzers and biomarker tests, as well as a new one-step rapid test for canine heartworm detection. The partnership aimed to leverage MWI’s extensive nationwide distribution network to provide veterinary practices with greater access to affordable and high-efficiency diagnostic solutions. The Vcheck analyzers utilize advanced europium technology to deliver quantitative results for various biomarkers in minutes.
  • In January 2024, IDEXX Laboratories, Inc. announced the launch of the IDEXX inVue Dx Cellular Analyzer, a first-of-its-kind slide-free cellular analysis platform for veterinary clinics. This innovative point-of-care system utilizes artificial intelligence to detect common cytologic changes in ear and blood samples, providing practitioners with reference-laboratory quality results within approximately 10 minutes. By eliminating the manual steps associated with slide preparation and microscopy, the analyzer streamlines clinic workflows and enhances diagnostic confidence. The technology was designed to address the complexity and time constraints of traditional manual microscopy, offering multidimensional imaging of cells in their natural state.
  • In January 2024, Antech announced the launch of the Nu.Q Canine Cancer Test on its Heska Element i+ Immunodiagnostic Analyzer at the VMX meeting in Orlando. This breakthrough point-of-care diagnostic tool measures circulating nucleosomes to support the early detection of prevalent canine cancers, such as lymphoma and hemangiosarcoma. The test requires only a small plasma sample and delivers accurate results in approximately six minutes, enabling veterinarians to screen high-risk breeds and older dogs during routine wellness exams. This development represented a significant advancement in making affordable and rapid cancer screening accessible directly within the veterinary clinic.

Key Market Players

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Virbac SA
  • Heska Corporation
  • Thermo Fisher Scientific, Inc
  • Mindray Medical International Limited
  • Esaote S.P.A.
  • FUJIFILM Corporation
  • Woodley Equipment Company Ltd
  • Getein Biotech Inc.

By Product

By Animal Type {Companion Animals

By Sample Type

By Indication

By Testing Category

By End User

By Region

  • Consumables
  • Reagents
  • Kits
  • Instruments & Devices
  • Dogs
  • Cats
  • Horses
  • Others
  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others
  • Infectious Disease
  • General Ailments
  • Others
  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others
  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Veterinary Point of Care Diagnostics Market, By Product:
  • Consumables
  • Reagents
  • Kits
  • Instruments & Devices
  • Veterinary Point of Care Diagnostics Market, By Animal Type {Companion Animals:
  • Dogs
  • Cats
  • Horses
  • Others
  • Veterinary Point of Care Diagnostics Market, By Sample Type:
  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others
  • Veterinary Point of Care Diagnostics Market, By Indication:
  • Infectious Disease
  • General Ailments
  • Others
  • Veterinary Point of Care Diagnostics Market, By Testing Category:
  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others
  • Veterinary Point of Care Diagnostics Market, By End User:
  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others
  • Veterinary Point of Care Diagnostics Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Point of Care Diagnostics Market.

Available Customizations:

Global Veterinary Point of Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Point of Care Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Veterinary Point of Care Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Product (Consumables, Reagents, Kits, Instruments & Devices)

5.2.2.  By Animal Type {Companion Animals (Dogs, Cats, Horses, Others)

5.2.3.  By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others)

5.2.4.  By Indication (Infectious Disease, General Ailments, Others)

5.2.5.  By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others)

5.2.6.  By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others)

5.2.7.  By Region

5.2.8.  By Company (2025)

5.3.  Market Map

6.    North America Veterinary Point of Care Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product

6.2.2.  By Animal Type {Companion Animals

6.2.3.  By Sample Type

6.2.4.  By Indication

6.2.5.  By Testing Category

6.2.6.  By End User

6.2.7.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Veterinary Point of Care Diagnostics Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Product

6.3.1.2.2.  By Animal Type {Companion Animals

6.3.1.2.3.  By Sample Type

6.3.1.2.4.  By Indication

6.3.1.2.5.  By Testing Category

6.3.1.2.6.  By End User

6.3.2.    Canada Veterinary Point of Care Diagnostics Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Product

6.3.2.2.2.  By Animal Type {Companion Animals

6.3.2.2.3.  By Sample Type

6.3.2.2.4.  By Indication

6.3.2.2.5.  By Testing Category

6.3.2.2.6.  By End User

6.3.3.    Mexico Veterinary Point of Care Diagnostics Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Product

6.3.3.2.2.  By Animal Type {Companion Animals

6.3.3.2.3.  By Sample Type

6.3.3.2.4.  By Indication

6.3.3.2.5.  By Testing Category

6.3.3.2.6.  By End User

7.    Europe Veterinary Point of Care Diagnostics Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Product

7.2.2.  By Animal Type {Companion Animals

7.2.3.  By Sample Type

7.2.4.  By Indication

7.2.5.  By Testing Category

7.2.6.  By End User

7.2.7.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Veterinary Point of Care Diagnostics Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Product

7.3.1.2.2.  By Animal Type {Companion Animals

7.3.1.2.3.  By Sample Type

7.3.1.2.4.  By Indication

7.3.1.2.5.  By Testing Category

7.3.1.2.6.  By End User

7.3.2.    France Veterinary Point of Care Diagnostics Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Product

7.3.2.2.2.  By Animal Type {Companion Animals

7.3.2.2.3.  By Sample Type

7.3.2.2.4.  By Indication

7.3.2.2.5.  By Testing Category

7.3.2.2.6.  By End User

7.3.3.    United Kingdom Veterinary Point of Care Diagnostics Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Product

7.3.3.2.2.  By Animal Type {Companion Animals

7.3.3.2.3.  By Sample Type

7.3.3.2.4.  By Indication

7.3.3.2.5.  By Testing Category

7.3.3.2.6.  By End User

7.3.4.    Italy Veterinary Point of Care Diagnostics Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Product

7.3.4.2.2.  By Animal Type {Companion Animals

7.3.4.2.3.  By Sample Type

7.3.4.2.4.  By Indication

7.3.4.2.5.  By Testing Category

7.3.4.2.6.  By End User

7.3.5.    Spain Veterinary Point of Care Diagnostics Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Product

7.3.5.2.2.  By Animal Type {Companion Animals

7.3.5.2.3.  By Sample Type

7.3.5.2.4.  By Indication

7.3.5.2.5.  By Testing Category

7.3.5.2.6.  By End User

8.    Asia Pacific Veterinary Point of Care Diagnostics Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Product

8.2.2.  By Animal Type {Companion Animals

8.2.3.  By Sample Type

8.2.4.  By Indication

8.2.5.  By Testing Category

8.2.6.  By End User

8.2.7.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Veterinary Point of Care Diagnostics Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Product

8.3.1.2.2.  By Animal Type {Companion Animals

8.3.1.2.3.  By Sample Type

8.3.1.2.4.  By Indication

8.3.1.2.5.  By Testing Category

8.3.1.2.6.  By End User

8.3.2.    India Veterinary Point of Care Diagnostics Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Product

8.3.2.2.2.  By Animal Type {Companion Animals

8.3.2.2.3.  By Sample Type

8.3.2.2.4.  By Indication

8.3.2.2.5.  By Testing Category

8.3.2.2.6.  By End User

8.3.3.    Japan Veterinary Point of Care Diagnostics Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Product

8.3.3.2.2.  By Animal Type {Companion Animals

8.3.3.2.3.  By Sample Type

8.3.3.2.4.  By Indication

8.3.3.2.5.  By Testing Category

8.3.3.2.6.  By End User

8.3.4.    South Korea Veterinary Point of Care Diagnostics Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Product

8.3.4.2.2.  By Animal Type {Companion Animals

8.3.4.2.3.  By Sample Type

8.3.4.2.4.  By Indication

8.3.4.2.5.  By Testing Category

8.3.4.2.6.  By End User

8.3.5.    Australia Veterinary Point of Care Diagnostics Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Product

8.3.5.2.2.  By Animal Type {Companion Animals

8.3.5.2.3.  By Sample Type

8.3.5.2.4.  By Indication

8.3.5.2.5.  By Testing Category

8.3.5.2.6.  By End User

9.    Middle East & Africa Veterinary Point of Care Diagnostics Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Product

9.2.2.  By Animal Type {Companion Animals

9.2.3.  By Sample Type

9.2.4.  By Indication

9.2.5.  By Testing Category

9.2.6.  By End User

9.2.7.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Veterinary Point of Care Diagnostics Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Product

9.3.1.2.2.  By Animal Type {Companion Animals

9.3.1.2.3.  By Sample Type

9.3.1.2.4.  By Indication

9.3.1.2.5.  By Testing Category

9.3.1.2.6.  By End User

9.3.2.    UAE Veterinary Point of Care Diagnostics Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Product

9.3.2.2.2.  By Animal Type {Companion Animals

9.3.2.2.3.  By Sample Type

9.3.2.2.4.  By Indication

9.3.2.2.5.  By Testing Category

9.3.2.2.6.  By End User

9.3.3.    South Africa Veterinary Point of Care Diagnostics Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Product

9.3.3.2.2.  By Animal Type {Companion Animals

9.3.3.2.3.  By Sample Type

9.3.3.2.4.  By Indication

9.3.3.2.5.  By Testing Category

9.3.3.2.6.  By End User

10.    South America Veterinary Point of Care Diagnostics Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Animal Type {Companion Animals

10.2.3.  By Sample Type

10.2.4.  By Indication

10.2.5.  By Testing Category

10.2.6.  By End User

10.2.7.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Veterinary Point of Care Diagnostics Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Product

10.3.1.2.2.  By Animal Type {Companion Animals

10.3.1.2.3.  By Sample Type

10.3.1.2.4.  By Indication

10.3.1.2.5.  By Testing Category

10.3.1.2.6.  By End User

10.3.2.    Colombia Veterinary Point of Care Diagnostics Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Product

10.3.2.2.2.  By Animal Type {Companion Animals

10.3.2.2.3.  By Sample Type

10.3.2.2.4.  By Indication

10.3.2.2.5.  By Testing Category

10.3.2.2.6.  By End User

10.3.3.    Argentina Veterinary Point of Care Diagnostics Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Product

10.3.3.2.2.  By Animal Type {Companion Animals

10.3.3.2.3.  By Sample Type

10.3.3.2.4.  By Indication

10.3.3.2.5.  By Testing Category

10.3.3.2.6.  By End User

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Veterinary Point of Care Diagnostics Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Zoetis Inc.

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  IDEXX Laboratories, Inc.

15.3.  Virbac SA

15.4.  Heska Corporation

15.5.  Thermo Fisher Scientific, Inc

15.6.  Mindray Medical International Limited

15.7.  Esaote S.P.A.

15.8.  FUJIFILM Corporation

15.9.  Woodley Equipment Company Ltd

15.10.  Getein Biotech Inc.

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Veterinary Point of Care Diagnostics Market was estimated to be USD 2.12 Billion in 2025.

North America is the dominating region in the Global Veterinary Point of Care Diagnostics Market.

Home Care Settings segment is the fastest growing segment in the Global Veterinary Point of Care Diagnostics Market.

The Global Veterinary Point of Care Diagnostics Market is expected to grow at 10.79% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.